These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 36419876)

  • 41. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
    Wang N; Zhu L; Wang L; Shen Z; Huang X
    Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Comprehensive Role of High Mobility Group Box 1 (HMGB1) Protein in Different Tumors: A Pan-Cancer Analysis.
    Guan H; Zhong M; Ma K; Tang C; Wang X; Ouyang M; Qin R; Chen J; Zhu E; Zhu T; Lu Y; Liu Y; Tian C; Zheng Z
    J Inflamm Res; 2023; 16():617-637. PubMed ID: 36820147
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pan-Cancer analysis shows that ACO2 is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including hepatocellular carcinoma.
    Wang Z; Zheng W; Chen Z; Wu S; Chang H; Cai M; Cai H
    Front Oncol; 2022; 12():1055376. PubMed ID: 36531056
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A pan-cancer landscape of centromere proteins in tumorigenesis and anticancer drug sensitivity.
    Shi YX; Dai PH; Jiang YF; Wang YQ; Liu W
    Transl Oncol; 2023 May; 31():101658. PubMed ID: 36944275
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pan-cancer analysis supports MAPK12 as a potential prognostic and immunotherapeutic target in multiple tumor types, including in THCA.
    Wang J; Song Z; Ren L; Zhang B; Zhang Y; Yang X; Liu T; Gu Y; Feng C
    Oncol Lett; 2022 Dec; 24(6):445. PubMed ID: 36420075
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumor microenvironment-related gene selenium-binding protein 1 (SELENBP1) is associated with immunotherapy efficacy and survival in colorectal cancer.
    Zhu C; Wang S; Du Y; Dai Y; Huai Q; Li X; Du Y; Dai H; Yuan W; Yin S; Wang H
    BMC Gastroenterol; 2022 Oct; 22(1):437. PubMed ID: 36253721
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pan-Cancer Analysis of Microfibrillar-Associated Protein 2 (MFAP2) Based on Bioinformatics and qPCR Verification.
    Qiu Z; Xin M; Wang C; Zhu Y; Kong Q; Liu Z
    J Oncol; 2022; 2022():8423173. PubMed ID: 35211173
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A systematic analysis of
    Jiang Y; Wang X; Li L; He J; Jin Q; Long D; Liu C; Zhou W; Liu K
    Front Genet; 2022; 13():926943. PubMed ID: 35991552
    [No Abstract]   [Full Text] [Related]  

  • 49. Systematic pan-cancer analysis of the nicotinamide n-methyltransferase in human cancer.
    Cao L; Wu W; Deng X; Peng Y; Chen Y; Guo H; Wang L; Li X; Zhang Z; Shao Z
    Front Genet; 2022; 13():1000515. PubMed ID: 36386816
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comprehensive analysis of the protein phosphatase 2A regulatory subunit B56ε in pan-cancer and its role and mechanism in hepatocellular carcinoma.
    Wu HM; Huang YY; Xu YQ; Xiang WL; Yang C; Liu RY; Li D; Guo XF; Zhang ZB; Bei CH; Tan SK; Zhu XN
    World J Gastrointest Oncol; 2024 Feb; 16(2):475-492. PubMed ID: 38425404
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A pan-cancer analysis of the expression of STAT family genes in tumors and their relationship to the tumor microenvironment.
    Zhou M; Zhang P; Da M; Yang R; Ma Y; Zhao J; Ma T; Xia J; Shen G; Chen Y; Chen D
    Front Oncol; 2022; 12():925537. PubMed ID: 36176415
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MJDs family members: Potential prognostic targets and immune-associated biomarkers in hepatocellular carcinoma.
    Zhou L; Chen G; Liu T; Liu X; Yang C; Jiang J
    Front Genet; 2022; 13():965805. PubMed ID: 36159990
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic Significance and Immunological Role of FBXO5 in Human Cancers: A Systematic Pan-Cancer Analysis.
    Liu P; Wang X; Pan L; Han B; He Z
    Front Immunol; 2022; 13():901784. PubMed ID: 35720327
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comprehensive Analysis of the Oncogenic, Genomic Alteration, and Immunological Landscape of Cation-Chloride Cotransporters in Pan-Cancer.
    Wang J; Liu W; Xu W; Yang B; Cui M; Li Z; Zhang H; Jin C; Xue H; Zhang J
    Front Oncol; 2022; 12():819688. PubMed ID: 35372048
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Pan-cancer analysis of the expression pattern of long non-coding RNA MIR22HG].
    Wang H; Li W; Zhang D
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Apr; 42(4):473-485. PubMed ID: 35527483
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas.
    Wei C; Wang B; Peng D; Zhang X; Li Z; Luo L; He Y; Liang H; Du X; Li S; Zhang S; Zhang Z; Han L; Zhang J
    Front Immunol; 2022; 13():849592. PubMed ID: 35444654
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer.
    Li T; Yan Z; Wang W; Zhang R; Gan W; Lv S; Zeng Z; Hou Y; Yang M
    Front Mol Biosci; 2021; 8():687319. PubMed ID: 34938771
    [No Abstract]   [Full Text] [Related]  

  • 58. Prognostic value and immunological role of CSNK1D in human cancers.
    Wang J; Hu B; Wang W
    Aging (Albany NY); 2023 Sep; 15(17):8948-8975. PubMed ID: 37688771
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic value and immunological role of BAIAP2L2 in liver hepatocellular carcinoma: A pan-cancer analysis.
    Han X; Long W; Liu Y; Xu J
    Front Surg; 2022; 9():985034. PubMed ID: 36338652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.